Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD)
- PMID: 37291437
- DOI: 10.1208/s12249-023-02592-x
Development of Child-Friendly Lisdexamfetamine Chewable Tablets Using Ion Exchange Resin as a Taste-Masking Carrier Based on the Concept of Quality by Design (QbD)
Abstract
Taste masking is critical to improving the compliance of pediatric oral dosage forms. However, it is challenging for extremely bitter lisdexamfetamine dimesylate (LDX) with a long half-life and given in large dose. The present study aims to develop an immediate-release, taste-masked lisdexamfetamine chewable tablet. Lisdexamfetamine-resin complexes (LRCs) were prepared using the batch method. The molecular mechanism of taste masking was explored by PXRD, PLM, STA, and FT-IR. The results showed that taste masking was attributed to the ionic interaction between drug and the resin. The ion exchange process conformed to first-order kinetics. The rate-limiting step of drug release was the diffusion of ions inside the particles, and the concentration of H+ was the key factor for immediate release. The masking efficiency of the prepared LRCs in saliva exceeded 96%, and the drug could be completely released within 15 min in aqueous HCl (pH 1.2). Furthermore, the SeDeM expert system was used for the first time to comprehensively study the powder properties of LRCs and to quickly visualize their defects (compressibility, lubricity/stability, and lubricity/dosage). The selection of excipients was targeted rather than traditional screening, thus obtaining a robust chewable tablet formulation suitable for direct compression. Finally, the difference between chewable tablets containing LRCs and chewable tablets containing lisdexamfetamine dimesylate was compared by in vitro dissolution test, electronic tongue, and disintegration test. In conclusion, an immediate-released, child-friendly lisdexamfetamine chewable tablets without bitterness was successfully developed by the QbD approach, using the SeDeM system, which may help in further development of chewable tablets.
Keywords: SeDeM diagram expert system; chewable tablets; ion exchange resins; lisdexamfetamine dimesylate; taste masking.
© 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.Int J Pharm. 2013 Oct 15;455(1-2):31-9. doi: 10.1016/j.ijpharm.2013.07.072. Epub 2013 Aug 7. Int J Pharm. 2013. PMID: 23933050
-
Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction.Int J Pharm. 2018 Jul 10;545(1-2):163-169. doi: 10.1016/j.ijpharm.2018.05.004. Epub 2018 May 3. Int J Pharm. 2018. PMID: 29729403
-
Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.Drug Dev Ind Pharm. 2015 Jun;41(6):1006-16. doi: 10.3109/03639045.2014.922573. Epub 2014 May 28. Drug Dev Ind Pharm. 2015. PMID: 24865111 Clinical Trial.
-
Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.Acta Pharm. 2024 May 30;74(2):177-199. doi: 10.2478/acph-2024-0015. Print 2024 Jun 1. Acta Pharm. 2024. PMID: 38815202 Review.
-
SeDeM Expert System, an Innovative Tool for Developing Directly Compressible Tablets: A Review.Curr Drug Res Rev. 2021;13(1):16-24. doi: 10.2174/2589977512666200928113716. Curr Drug Res Rev. 2021. PMID: 32988362 Review.
Cited by
-
Critical View on the Qualification of Electronic Tongues Regarding Their Performance in the Development of Peroral Drug Formulations with Bitter Ingredients.Pharmaceutics. 2024 May 15;16(5):658. doi: 10.3390/pharmaceutics16050658. Pharmaceutics. 2024. PMID: 38794320 Free PMC article. Review.
-
Development of Palatable Amorphous Trazodone Hydrochloride Formulations via Ion Exchange.Pharmaceutics. 2025 Jul 27;17(8):972. doi: 10.3390/pharmaceutics17080972. Pharmaceutics. 2025. PMID: 40870995 Free PMC article.
-
Solid-State NMR Characterization of Mefloquine Resinate Complexes Designed for Taste-Masking Pediatric Formulations.Pharmaceuticals (Basel). 2024 Jul 2;17(7):870. doi: 10.3390/ph17070870. Pharmaceuticals (Basel). 2024. PMID: 39065722 Free PMC article.
-
Dual-Responsive Ion-Exchange Resin Encapsulated Atomoxetine Hydrochloride for Taste-Masking and Biphasic Release.AAPS PharmSciTech. 2025 Apr 29;26(5):118. doi: 10.1208/s12249-025-03111-w. AAPS PharmSciTech. 2025. PMID: 40301192
-
Taste Masking of Primaquine Phosphate: A Comparative Evaluation of Three Taste Masking Agents.AAPS PharmSciTech. 2025 Jun 11;26(5):168. doi: 10.1208/s12249-025-03162-z. AAPS PharmSciTech. 2025. PMID: 40500474
References
-
- Blick SK, Keating GM. Lisdexamfetamine. Paediatr Drugs. 2007;9(2):129–35; discussion 36-8. https://doi.org/10.2165/00148581-200709020-00007 . - DOI - PubMed
-
- Elia J, Easley C, Kirkpatrick P. Lisdexamfetamine dimesylate. Nat Rev Drug Discov. 2007;6(5):343–4. https://doi.org/10.1038/nrd2315 . - DOI - PubMed
-
- Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6(1):317–27. https://doi.org/10.2147/ndt.s9749 . - DOI - PubMed - PMC
-
- Boellner SW, Stark JG, Krishnan S, Zhang Y. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. Clin Ther. 2010;32(2):252–64. https://doi.org/10.1016/j.clinthera.2010.02.011 . - DOI - PubMed
-
- Krishnan SM, Stark JG. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24(1):33–40. https://doi.org/10.1185/030079908x242737 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources